• Stromal Therapeutics AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-320.3.085.496-4
    Sector: Production of pharmaceutical substances

    Age of the company

    6 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    180'000

    Employees

    PremiumPremium

    Active brands

    0

    Other addresses

    Reports for Stromal Therapeutics AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Stromal Therapeutics AG

    • Stromal Therapeutics AG in Basel is a Company limited by shares (AG) from the sector «Production of pharmaceutical substances». Stromal Therapeutics AG is active.
    • The management of the company Stromal Therapeutics AG, which was founded on the 05.12.2018, consists of 5 persons.
    • The company has last changed their commercial register entry on 25.08.2023, under «Notifications» you will find all changes.
    • In the commercial register the company Stromal Therapeutics AG is registered under the UID CHE-370.604.771.
    • Companies with the same address as Stromal Therapeutics AG: ccloop, GRENKEFACTORING AG, Hälg & Co. AG, Zweigniederlassung Basel.

    Commercial register information

    Source: SOGC

    Sector

    Production of pharmaceutical substances

    Purpose (Original language)

    Die Gesellschaft bezweckt die Entwicklung, Herstellung, Vertrieb und Lizenzierung von diagnostischen und pharmazeutischen Produkten und Verfahren zur Therapie, Prävention und Diagnose von Krankheiten, insbesondere im Bereich von Tumorerkrankungen und in- flammatorischen Krankheiten. Die Gesellschaft kann Zweigniederlassungen und Tochtergesellschaften im In- und Ausland errichten und sich an anderen Unternehmen im In- und Ausland beteiligen sowie alle Geschäfte tätigen, die direkt oder indirekt mit ihrem Zweck in Zusammenhang stehen. Die Gesellschaft kann im In- und Ausland Grundeigentum erwerben, belasten, veräussern und verwalten. Sie kann auch Finanzierungen für eigene oder fremde Rechnung vornehmen sowie Garantien und Bürgschaften für Tochtergesellschaften und Dritte eingehen.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Haussmann Revision AG
    Zürich 10.12.2018

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Stromal Therapeutics SA
    • Stromal Therapeutics Ltd
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Stromal Therapeutics AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 230825/2023 - 25.08.2023
    Categories: Change in management

    Publication number: HR02-1005823865, Commercial Registry Office Basel-Stadt, (270)

    Stromal Therapeutics AG, in Basel, CHE-370.604.771, Aktiengesellschaft (SHAB Nr. 193 vom 05.10.2022, Publ. 1005576090).

    Eingetragene Personen neu oder mutierend:
    Zangvil, Dr. Eliezer, israelischer Staatsangehöriger, in Basel, Mitglied des Verwaltungsrates, ohne Zeichnungsberechtigung.

    SOGC 221005/2022 - 05.10.2022
    Categories: Change in capital

    Publication number: HR02-1005576090, Commercial Registry Office Basel-Stadt, (270)

    Stromal Therapeutics AG, in Basel, CHE-370.604.771, Aktiengesellschaft (SHAB Nr. 184 vom 22.09.2022, Publ. 1005567050).

    Statutenänderung:
    01.09.2022.

    Aktienkapital neu:
    CHF 180'000.00 [bisher: CHF 150'000.00].

    Liberierung Aktienkapital neu:
    CHF 180'000.00 [bisher: CHF 150'000.00].

    Aktien neu:
    180'000 Namenaktien zu CHF 1.00 [bisher: 150'000 Namenaktien zu CHF 1.00]. Ordentliche Erhöhung des Aktienkapitals.

    SOGC 220922/2022 - 22.09.2022
    Categories: Change in management

    Publication number: HR02-1005567050, Commercial Registry Office Basel-Stadt, (270)

    Stromal Therapeutics AG, in Basel, CHE-370.604.771, Aktiengesellschaft (SHAB Nr. 171 vom 05.09.2022, Publ. 1005554481).

    Eingetragene Personen neu oder mutierend:
    Engetschwiler, Céline, von Waldkirch, in Waldkirch, mit Kollektivunterschrift zu zweien.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm